Company Filing History:
Years Active: 2015
Title: Judith Lalonde: Innovator in IDO Inhibitors
Introduction
Judith Lalonde is a prominent inventor based in Bryn Mawr, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of IDO inhibitors. Her work focuses on compounds that modulate the activity of indoleamine 2,3-dioxygenase, which plays a crucial role in immunosuppression.
Latest Patents
Judith holds 1 patent related to IDO inhibitors. The patent includes compounds according to specific formulas and pharmaceutical compositions that are useful for treating conditions associated with indoleamine 2,3-dioxygenase. These compounds are designed to enhance the effectiveness of anti-cancer treatments and address immunosuppression linked to infectious diseases.
Career Highlights
Throughout her career, Judith has worked with notable organizations such as Newlink Genetics Corporation and the Lankenau Institute for Medical Research. Her expertise in the field has allowed her to contribute to innovative solutions in medical research and treatment.
Collaborations
Judith has collaborated with esteemed colleagues, including Mario Mautino and Sanjeev Kumar. These partnerships have furthered her research and development efforts in the pharmaceutical industry.
Conclusion
Judith Lalonde's work in developing IDO inhibitors showcases her dedication to advancing medical science. Her contributions are vital in the fight against cancer and infectious diseases, making her a noteworthy figure in the field of innovation.